Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank29
Studio
Year-over-Year Change

Return on equity

Latest
-33.95%
↓ 141% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-14.06%
Historical baseline
PeriodValueYoY Change
2025-33.95%-7.2%
2024-31.66%+16.8%
2023-38.07%+28.2%
2022-53.04%-112.3%
2021-24.98%-281.9%
2020-6.54%-116.1%
201940.74%+16.4%
201835.00%-